These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 37712675)

  • 1. Optimizing patient selection for primary prevention implantable cardioverter-defibrillator implantation: utilizing multimodal machine learning to assess risk of implantable cardioverter-defibrillator non-benefit.
    Kolk MZH; Ruipérez-Campillo S; Deb B; Bekkers EJ; Allaart CP; Rogers AJ; Van Der Lingen ACJ; Alvarez Florez L; Isgum I; De Vos BD; Clopton P; Wilde AAM; Knops RE; Narayan SM; Tjong FVY
    Europace; 2023 Aug; 25(9):. PubMed ID: 37712675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors predisposing to ventricular tachyarrhythmia leading to appropriate ICD intervention in patients with coronary artery disease or non-ischaemic dilated cardiomyopathy.
    Lelakowski J; Piekarz J; Rydlewska A; Majewski J; Senderek T; Ząbek A; Małecka B
    Kardiol Pol; 2012; 70(12):1264-75. PubMed ID: 23264245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implantable cardioverter defibrillators. Prophylactic use: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2005; 5(14):1-74. PubMed ID: 23074465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary prevention implantable cardioverter-defibrillator use in non-ischemic dilated cardiomyopathy based on arrhythmic risk stratification and left ventricular reverse remodeling prediction.
    Muhammed A; Abdelazeem M; Elewa MG; Sharief M; Ammar A
    Heart Fail Rev; 2023 Jan; 28(1):229-240. PubMed ID: 35587303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eligibility for subcutaneous implantable cardioverter-defibrillator in congenital heart disease.
    Wang L; Javadekar N; Rajagopalan A; Rogovoy NM; Haq KT; Broberg CS; Tereshchenko LG
    Heart Rhythm; 2020 May; 17(5 Pt B):860-869. PubMed ID: 32354451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The need to modify patient selection to improve the benefits of implantable cardioverter-defibrillator for primary prevention of sudden death in non-ischaemic dilated cardiomyopathy.
    Disertori M; Quintarelli S; Mazzola S; Favalli V; Narula N; Arbustini E
    Europace; 2013 Dec; 15(12):1693-701. PubMed ID: 23946316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapy optimization in patients with heart failure: the role of the wearable cardioverter-defibrillator in a real-world setting.
    Röger S; Rosenkaimer SL; Hohneck A; Lang S; El-Battrawy I; Rudic B; Tülümen E; Stach K; Kuschyk J; Akin I; Borggrefe M
    BMC Cardiovasc Disord; 2018 Mar; 18(1):52. PubMed ID: 29544442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determinants of patient survival rate after implantation of a cardioverter-defibrillator without resynchronisation capability.
    Lelakowski J; Piekarz J; Rydlewska A; Majewski J; Senderek T; Ząbek A; Małecka B
    Kardiol Pol; 2012; 70(11):1099-110. PubMed ID: 23180517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multimodal explainable artificial intelligence identifies patients with non-ischaemic cardiomyopathy at risk of lethal ventricular arrhythmias.
    Kolk MZH; Ruipérez-Campillo S; Allaart CP; Wilde AAM; Knops RE; Narayan SM; Tjong FVY;
    Sci Rep; 2024 Jun; 14(1):14889. PubMed ID: 38937555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kidney dysfunction and deterioration of ejection fraction pose independent risk factors for mortality in implantable cardioverter-defibrillator recipients for primary prevention.
    Kreuz J; Horlbeck F; Schrickel J; Linhart M; Fimmers R; Mellert F; Nickenig G; Schwab JO
    Clin Cardiol; 2012 Sep; 35(9):575-9. PubMed ID: 22707222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical effectiveness of primary prevention implantable cardioverter-defibrillators: results of the EU-CERT-ICD controlled multicentre cohort study.
    Zabel M; Willems R; Lubinski A; Bauer A; Brugada J; Conen D; Flevari P; Hasenfuß G; Svetlosak M; Huikuri HV; Malik M; Pavlović N; Schmidt G; Sritharan R; Schlögl S; Szavits-Nossan J; Traykov V; Tuinenburg AE; Willich SN; Harden M; Friede T; Svendsen JH; Sticherling C; Merkely B;
    Eur Heart J; 2020 Sep; 41(36):3437-3447. PubMed ID: 32372094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sudden cardiac death after myocardial infarction: individual participant data from pooled cohorts.
    Peek N; Hindricks G; Akbarov A; Tijssen JGP; Jenkins DA; Kapacee Z; Parkes LM; van der Geest RJ; Longato E; Sprague D; Taleb Y; Ong M; Miller CA; Shamloo AS; Albert C; Barthel P; Boveda S; Braunschweig F; Johansen JB; Cook N; de Chillou C; Elders P; Faxén J; Friede T; Fusini L; Gale CP; Jarkovsky J; Jouven X; Junttila J; Kautzner J; Kiviniemi A; Kutyifa V; Leclercq C; Lee DC; Leigh J; Lenarczyk R; Leyva F; Maeng M; Manca A; Marijon E; Marschall U; Merino JL; Mont L; Nielsen JC; Olsen T; Pester J; Pontone G; Roca I; Schmidt G; Schwartz PJ; Sticherling C; Suleiman M; Taborsky M; Tan HL; Tfelt-Hansen J; Thiele H; Tomaselli GF; Verstraelen T; Vinayagamoorthy M; Olesen KKW; Wilde A; Willems R; Wu KC; Zabel M; Martin GP; Dagres N
    Eur Heart J; 2024 Nov; 45(43):4616-4626. PubMed ID: 39378245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival, ventricular arrhythmia, and implantable cardioverter-defibrillator usefulness in toxic cardiomyopathy due to substance abuse.
    Dognin N; Rimac G; Domain G; Cinq-Mars A; Massot M; Turgeon PY; Dubois-Sénéchal SM; Bourgault C; Morin J; Bernier M; Beaudoin J; Laflamme M; Charbonneau E; Strubé C; Voisine P; Philippon F; Belzile D; Sénéchal M
    Pacing Clin Electrophysiol; 2023 Jul; 46(7):645-656. PubMed ID: 37247219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Left Ventricular Entropy Is a Novel Predictor of Arrhythmic Events in Patients With Dilated Cardiomyopathy Receiving Defibrillators for Primary Prevention.
    Muthalaly RG; Kwong RY; John RM; van der Geest RJ; Tao Q; Schaeffer B; Tanigawa S; Nakamura T; Kaneko K; Tedrow UB; Stevenson WG; Epstein LM; Kapur S; Zei PC; Koplan BA
    JACC Cardiovasc Imaging; 2019 Jul; 12(7 Pt 1):1177-1184. PubMed ID: 30121262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implantable cardioverter defibrillator therapy activation for high risk patients with relatively well preserved left ventricular ejection fraction. Does it really work?
    Gatzoulis KA; Tsiachris D; Dilaveris P; Archontakis S; Arsenos P; Vouliotis A; Sideris S; Trantalis G; Kartsagoulis E; Kallikazaros I; Stefanadis C
    Int J Cardiol; 2013 Aug; 167(4):1360-5. PubMed ID: 22534047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple autonomic and repolarization investigation of sudden cardiac death in dilated cardiomyopathy and controls.
    Pezawas T; Diedrich A; Winker R; Robertson D; Richter B; Wang L; Byrne DW; Schmidinger H
    Circ Arrhythm Electrophysiol; 2014 Dec; 7(6):1101-8. PubMed ID: 25262115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-terminal pro-B-type natriuretic peptide is a specific predictor of appropriate device therapies in patients with primary prevention implantable cardioverter-defibrillators.
    Sroubek J; Matos J; Locke A; Kaplinskiy V; Levine YC; Shen C; Buxton AE
    Heart Rhythm; 2021 Jan; 18(1):71-78. PubMed ID: 32866691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decision-making regarding subcutaneous implantable cardioverter defibrillator as primary prevention in patients with low ejection fraction.
    Ngan HT; Li KY; Wong SL; Tse HF
    Pacing Clin Electrophysiol; 2024 Oct; 47(10):1285-1292. PubMed ID: 39161154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Arrhythmia, device interventions and mortality analysis in patients with implanted cardioverter-defibrillator with/without resynchronisation therapy in dilative cardiomyopathy in primary prevention of sudden cardiac death].
    Lelakowski J; Pudło J; Lelakowska-Pieła M; Rydlewska A; Piekarz J; Domaracki D
    Pol Merkur Lekarski; 2016 Apr; 40(238):216-22. PubMed ID: 27137820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Occurrence of Implantable Cardioverter Defibrillator Therapies After Generator Replacement in Patients Who No Longer Meet Primary Prevention Indications.
    Kawata H; Hirai T; Doukas D; Hirai R; Steinbrunner J; Wilson J; Noda T; Hsu J; Krummen D; Feld G; Wilber D; Santucci P; Birgersdotter-Green U
    J Cardiovasc Electrophysiol; 2016 Jun; 27(6):724-9. PubMed ID: 26915696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.